Anja Poulsen

Ustekinumab for ileal stricturing #Crohns, out now in @JCC_IBD! Thank you @IBD_FloMD for your mentorship and guidance and to all co-authors for your precious contributions, from around the 🌎🇦🇪 🇨🇦🇺🇸 @CathyLuMD @MRegueiroMD @JosephHabibi_MD @DavidBruiningMD @IBDBen @HolubarStefan

@HolubarStefan @AnthonydeBuck @JosephHabibi_MD @KatieFalloonMD @CathyLuMD @DavidBruiningMD @CharlieMuz @BoutrosMarylise @AsadurRahman87 @BettenworthDb @ShomronH @FernandoMagro6 @RPanaccione @IBDProNews @JCC_IBD @ibdseb @crohnsfighting @CrohnsColitisFn @DocCohenIBD @GrahnazB

Ustekinumab for ileal stricturing Crohn’s disease—an international multicenter retrospective cohort study academic.oup.com/ecco-jcc/artic…. Congratulations to @SaraElOualiMD and the #STARConsortium. Stay tuned for more coming soon… @tinahamd @ownyourcrohns @MRegueiroMD @DrsMeena

Another successful weekend in Chicago with the @AmCollegeGastro training committee. Special thanks to @BilalMohammadMD and #StephAyala for your leadership. Expect great projects for trainees as always. #MedEd #ACG2026

Advancing drug discovery for Inflammatory bowel diseases through human intestinal organoid-based models: Expert Opinion on Drug Discovery ⁦@MRegueiroMD⁩ ⁦@JosephHabibi_MD⁩ tandfonline.com/doi/full/10.10…

Great leadership and idea by ⁦@DignassAxel⁩ with #IBDEssentials vodcasts. Global #IBD experts deliver content relevant to your practice - now and in the future. Tune in … 👇🏻 ⁦@MRegueiroMD⁩ ⁦@RPanaccione⁩ ⁦@tinahamd⁩ ⁦ podcasts.apple.com/us/podcast/ibd…

IBUS celebrates International Women's Day 🙌💜 Women members of the IBUS committees and office, around the world!

#CGH4ALL @AGA_CGH 📣 🧬 Two colorectal cancer pathways. 🤔 What happens when both are present at the same colonoscopy? 📊 Large surveillance study suggests markedly higher future neoplasia risk with synchronous adenoma + serrated lesions Worth a closer look 👇 🔗 doi.org/10.1016/j.cgh.… Reported by @MSohaibMD @molmesele @AasmaShaukatMD @jkarlitzMD @DMGrayMD @AustinChiangMD @vaibhav_manu @JasonSamarasena

#CGH4ALL @AGA_CGH 📣 🧬 Are all “advanced adenomas” truly equal? 📊 35,941-patient registry study 🔎 10-19 mm tubular adenomas vs ≥20 mm / villous / HGD ⚖️ Adjusted risks largely overlap ⚠️ Yet CRC risk numerically higher in the modified AA group 🔗 doi.org/10.1016/j.cgh.… Reported by @MSohaibMD @samirguptaGI @JasonDominitz @swatigp @DrMohdZein @dagreenwald  @HHussan_MD @SigridYoungMD @JeffLeeMD

@mamatocrohns @IBD_FloMD Free access to STENOVA study abstract #ECCO2026: #google_vignette" target="_blank" rel="nofollow noopener">academic.oup.com/ecco-jcc/artic…

🔬Exciting round 1 call for the CONSTRICT 2 RAND exercise led by @BettenworthDb and #STARConsortium. After the encouraging results from STENOVA presented at #ECCO2026 it is time to build the next gen approach to testing medical anti-stricture therapies 🔬

@JulsgaardMette Looking forward to it🌟

Join this excellent conference in Rome🇮🇹, November 13-14, 2026

First time seeing my mentor @IBD_FloMD FLO in person in over five years—last was late 2020 when I left Cleveland.What's changed? FLO’s been leading breakthroughs in intestinal fibrosis, from clinical endpoints to drug development. I’ve grown step by step from a small team.

What hasn’t? FLO’s support for me. The guidance, the encouragement, introducing me to everyone he knows—that kind of nice, that kind of gentle, it’s still the same. That’s what makes the best mentor. See you next time @IBD_FloMD

Outstanding work being showcased at #ECCO2026 posters. Thank you @Y_ECCO_IBD for the chance to chair poster rounds. @Bealoquebea

Very excited to be a board member of @YOGI_IBD and bring forward the educational and research opportunities on a global level. #ECCO26 meeting off to a great start

CONGRATULATIONS! 👏👏🎉 @novakkerri is the new @BowelUltrasound president!! 2333 members from 85 countries. ❤️Growth and collaborations! @RPanaccione @guthealthmd @kennethernest @joelle_stpierre @amelia_kellar @DrMikeDolinger @iUSCAN @MariangelaAllo3 @RuneWilkens @iuschris

@IBD_FloMD ⭐️reveals promising 👏phase2a anti fibrotic, ontunisertib, TGF B receptor antagonist, in TI Crohn’s strictures x 12 wks. #starconsortium 👉potential anti 🔥 ⬇️SES-CD ⬇️pre stenotic dilation ⬇️stricture length x 2cm and bowel wall thickness

#ECCO2026 opening with an patient who suffered from IBD is informative of their commitment to the real mission in Holistic IBD care. Ciara Drohan @ciarad2708 moving moments - I’ve had more years w/ IBD than w/o - w/ the amount of doctors who have examined my complex IBD, I’ve lost all my dignity - remember that all you learn in this conference should go back to the patient at the end & more ❤️